To clarify, Emvision are taking the 510k pathway rather than De Novo . Previous company presentations had the FDA 510ķ clearance for Gen 1 in FY25. My understanding is it's simpler, faster and cheaper.
To clarify, Emvision are taking the 510k pathway rather than De...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.030(1.44%) |
Mkt cap ! $175.1M | |||
| Open | High | Low | Value | Volume |
| $2.08 | $2.14 | $2.04 | $60.42K | 29.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 395 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.17 | 985 | 2 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| EMV (ASX) Chart |